Main

Human placental villi are covered by terminally differentiated, multinucleated syncytiotrophoblasts that are in direct contact with maternal blood. The subjacent mononucleated cytotrophoblasts provide a proliferative, stem cell population that differentiates and fuses to replenish the syncytium. Turnover of the trophoblast bi-layer occurs, in part, through apoptosis (1, 2). The balance of proliferation, differentiation, and apoptosis in the trophoblast layer of villi ultimately determines the mass of functional trophoblast available to regulate nutrient and waste exchange between the maternal and fetal circulations. Preeclampsia and fetal growth restriction (FGR) are associated with placental dysfunction, including villous hypoxia, altered differentiation and enhanced apoptosis in trophoblast (3–6). We previously showed that hypoxia hinders differentiation (7) and enhances apoptosis (8) in cultured trophoblasts from term placentas. Importantly, we found that the cytotrophoblasts were more susceptible than syncytiotrophoblasts to hypoxia-induced apoptosis.

The regulation of apoptotic cell death is complex (9). Multiple ligand-receptor interactions and diverse stimuli that modulate mitochondrial function converge to enhance the activity of initiator caspases, cysteine proteases that self-amplify their enzymatic activity when stimulated. These enzymes activate downstream effector caspases that cleave membrane, cytoplasmic, and nuclear components, effectively dismantling the cell. Caspases are well known for their role in cell suicide by apoptosis, but recent studies indicate they also play a role in cell proliferation and differentiation (10–12). Knowledge of the expression and activity of caspases in placental villi and cultured trophoblasts is in its infancy (13–15). The proforms of the initiator caspase 8 and the effector caspases 3, 6, and 7 are expressed in villous cytotrophoblast and syncytiotrophoblasts. Indirect evidence from immunohistochemical studies suggests that the fully active forms of these enzymes may be differentially expressed in both cytotrophoblast and syncytiotrophoblast on placental villi. We chose to examine two initiator caspases, 8 and 9, and two effector caspases, 3 and 6, because they are pivotal in both the ligand-receptor and the mitochondrial pathways to apoptotic cell death (16, 17). We tested the hypothesis that trophoblast differentiation alters the basal activities of caspases in primary cultures of human trophoblasts from term placental villi.

MATERIALS AND METHODS

Cell isolation and culture.

Informed consent for the use of human placentas was obtained by a protocol approved by the Institutional Review Board of Washington University, School of Medicine. Placentas were obtained immediately after term singleton deliveries following uncomplicated pregnancies. Cytotrophoblasts were isolated by the trypsin-DNase, Percoll (Pharmacia, Piscataway, NJ, U.S.A.) gradient centrifugation method described by Kliman et al.(18). with modifications (8). The cell isolate and culture characteristics in vitro have been previously described (7, 8). Control cytotrophoblasts were plated on polystyrene plates (Becton Dickinson, Franklin Lakes, NJ, U.S.A.) in duplicates or triplicates at 3 × 105 cells/cm2 in medium 199 (Tissue Culture Facility, WA University) with 10% fetal bovine serum (Hyclone, Logan, UT, U.S.A.) 20 mmol N-[2-hydroxyethyl] piperazine-N-[2-ethanesulfonic acid] (HEPES; Sigma Chemical Co., St. Louis MO, U.S.A.), and 2 mmol l-glutamine (Sigma Chemical Co., St. Louis, MO, U.S.A.) in a 5% carbon dioxide-air atmosphere at 37°C. Where indicated, cultures were supplemented with one or more of the following compounds: the pan-caspase inhibitor ZVAD-FMK (30 μM; Enzyme System Products, Livermore, CA, U.S.A.), colchicine (250 μM; Sigma Chemical Co., St. Louis, MO, U.S.A.), DMSO (DMSO; 1.5% vol/vol; Sigma Chemical Co.), epidermal growth factor (EGF; 100ng/mL; Upstate Biotechnology, Lake Placid, NY, U.S.A.), or the EGF receptor (EGFR) antagonist AG1478 (1 μM; Calbiochem, San Diego, CA, U.S.A.). Media were replaced every 24h, and supernatants were stored at −20°C until assayed.

Hormone assays.

Culture supernatants were assayed for hCG in duplicates by ELISA (DRG Diagnostics, Marburg, Germany) according to the manufacturer's instructions. Values represent mean (±SD) mIU/mL of hCG secreted in the previous 24 h.

Expression analysis.

Cell lysis, sonication, PAGE and transfer were performed as previously described (8), modified to use 30 μg protein per lane and 10% skim milk for blocking nonspecific proteins. Membranes were incubated overnight at 4°C with each of the following primary antibodies diluted 1:100 with TBST: goat polyclonal anti-pro-caspase 3 (Santa Cruz, Santa Cruz, CA, U.S.A.), rabbit polyclonal anti-pro-caspase 6 (Cell Signaling Technology, Beverly, MA, U.S.A.), goat polyclonal anti-pro-caspase 8 (Santa Cruz), and rabbit polyclonal anti-pro-caspase 9 (Cell Signaling Technology). Subsequently, the blot was incubated for 1 h with HRP-conjugated secondary antibody (Santa Cruz), washed, and processed for luminescence using Amersham ECL kit (Amersham Pharmacia Biotech). The densitometric analysis was performed using a Molecular Dynamics densitometer and ImageQuant v. 3.3 software (Molecular Dynamics, Sunnyvale, CA, U.S.A.).

Caspase Activity Assays.

Cells were lysed in buffer containing 10 mM HEPES, pH 7.4, 7.5 mM MgCl2, 1% Triton X-100, 2 mM EGTA, 1 mM DTT, and protease inhibitor cocktail (Sigma Chemical Co.). Samples were sonicated with one 10 second burst using a sonic dismembrator (Fisher, Pittsburgh, PA, U.S.A.) and centrifuged at 10,000 g for 20 min. Protein concentration of the resulting supernatant was determined with the Bio-Rad DC protein assay kit (BioRad, Hercules, CA, U.S.A.). Caspase assays were performed in triplicate with 30 μg protein per well and activity was measured in a FluoroCount microplate fluorometer (Packard, Meridan, CT, U.S.A.). This assay quantified the fluorescence that resulted from proteolytic cleavage of caspase specific synthetic peptides linked to 7-amino-4-methylcoumarin (AMC). Once cleaved from the substrate, the AMC emitted fluorescence at 430–460 nm when excited at 365–380 nm. Assay buffer consisted of 10 mM HEPES, pH 7.4, 50 mM KCl, 10% sucrose, and 3 mM DTT. The lysates were incubated in 96 well plates in the dark at room temperature for 3 h with one of the following caspase specific substrates in assay buffer: Ac-DEVD-AMC (caspase-3; Anaspec, San Jose, CA, U.S.A.), Ac-VEID-AMC (caspase-6; Calbiochem, San Diego, CA, U.S.A.), Ac-IETD-AMC (caspase-8; Anaspec), and Ac-LEHD-AMC (caspase-9; Anaspec). Background fluorescence from wells without protein was subtracted, and data were expressed as corrected relative fluorescence units (cRFU). There was no difference in caspase activity for cells cultured freshly after isolation compared with cells cultured after freezing (data not shown). We thus used previously frozen cells for our experiments.

Statistical analysis.

Data are mean ± SD. Comparisons were made using t test or one-way ANOVA with Bonferroni correction where multiple comparisons were made. A p < 0.05 was significant.

RESULTS

Cells cultured 24 h under standard conditions were predominantly the less differentiated, mononucleated cytotrophoblasts while cultures at 72 h exhibited abundant multi-nucleated syncytiotrophoblasts, indicative of morphologic differentiation. The differentiation of the trophoblast cultures was confirmed by the marked rise in the media level of hCG during culture (data not shown), as previously described (7).

We used western analysis to determine expression of pro-caspases in trophoblasts cultured for 24 h and for 72 h. The pro-caspases examined included two effector enzymes, 3 and 6, and two initiator caspases, 8 and 9 (16, 17). We found that all four pro-caspases were detectable in trophoblasts at both 24 h and 72 h of culture (Fig. 1). Pro-caspase 3 showed a 2-fold higher level of expression in cells cultured 24 h compared with those cultured 72 h. There was no difference in relative expression for pro-caspases 6, 8, and 9 between the two-trophoblast phenotypes.

Figure 1
figure 1

Expression of pro-caspases at 24 h and 72 h in primary trophoblasts cultured in medium 199, as shown by western blot. Time points are represented by duplicate wells from one placenta. Densitometric analysis revealed a 2-fold higher pro-caspase 3 expression in cells at 24 h compared with 72 h. (p = 0.03). There was no significant difference in expression for the other three pro-caspases in cells cultured 24 h compared with 72 h. The western blot is representative of four independent primary trophoblast cultures.

We next examined the activity of caspases 3, 6, 8, and 9 in trophoblasts cultured under standard conditions for 24 h and 72 h. The activity of each caspase was significantly higher in the less differentiated cells at 24 h compared with the more differentiated cells at 72h (Fig. 2A). To verify that the enzymatic cleavage of substrate was effected by caspases, we cultured cells for 30 min in the presence or absence of the pan-caspase inhibitor ZVAD-FMK before an additional 24h of culture before assay of caspase activities. The inhibitor significantly reduced the caspase activities to 5% to 25% of control levels (p < 0.001;Fig. 2B). Together, these data indicate that active caspases are expressed in both trophoblast phenotypes, but all four caspases exhibit a lower activity in syncytiotrophoblasts compared with cytotrophoblasts.

Figure 2
figure 2

Caspase activity in primary trophoblasts cultured 24 h or 72 h. (A) Data (mean ± SD) are activity of each caspase in trophoblasts cultured 72 h, expressed as a percentage of activity in control cells cultured 24 h. The mean caspase activity in cells at 24 hour was 11,688 cRFU for caspase 3, 2525 cRFU for caspase 6, 2848 cRFU for caspase 8, and 1567 cRFU for caspase 9. The activity of each caspase was significantly lower in the 72 h cells (p < 0.005). (B) The pan-caspase inhibitor Z-VAD significantly reduced caspase activity in cells cultured 24 h, compared with control cells without inhibitor (p < 0.001). The results are from five independent primary trophoblast cultures.

To rule out the possibility that time in culture, and not differentiation, diminished caspase activity, we analyzed caspase activity in trophoblast cultures grown 72 h in standard conditions to trophoblasts grown 72 h in the presence of either DMSO or colchicine. These chemicals are known to hinder trophoblast differentiation, resulting in cultures at 72 h with a predominantly cytotrophoblast phenotype (19, 20). Using these paradigms, we predicted that cells grown 72 h in the presence of DMSO or colchicine would have higher caspase activity than the more differentiated trophoblast in native conditions. We verified that a substantially lower media hCG level was present in cells cultured 72 h in media with DMSO (1.7 ± 2.2 mIU hCG/mL) or colchicine (1.5 ± 2.2 mIU hCG/mL), compared with control cells in medium 199 alone (483.9 ± 12.1 mIU hCG/mL). As predicted, the activity of each of the four caspases was significantly higher in cytotrophoblasts cultured in DMSO or colchicine for 72 h, compared with untreated cultures of syncytiotrophoblasts at 72 h (Fig. 3). These results support the previous findings that cytotrophoblasts exhibit a higher caspase activity, compared with the syncytiotrophoblasts.

Figure 3
figure 3

Caspase activity in primary trophoblasts cultured for 72 h in standard medium (control) or in the presence of colchicine (250 μM) or DMSO (1.5%, vol/vol). Data (mean ± SD) are corrected relative fluorescent units, as described in Methods. The activity of each caspase was significantly higher than control in both the colchicine (p < 0.01) and the DMSO (p < 0.005) paradigms. The results are from five independent primary trophoblast cultures.

EGF is known to enhance both morphologic and biochemical differentiation of trophoblasts in culture (21). We cultured cells 24 h in the presence or absence of EGF and measured hCG levels in medium and caspase activities in cell extracts. As expected (8, 21), hCG levels were substantially higher in cultures exposed to EGF (21.7 ± 5.6 mIU hCG/mL), compared with cultures without ligand (4.8 ± 5.6 mIU hCG/mL). Importantly, EGF treated cells showed significantly reduced activity of caspase 3, 6, and 9 at 24 h of culture, compared with control without ligand (Fig. 4A). The EGF effect was most pronounced on the activity of caspase 3, and this finding was consistent with the above results where caspase 3 showed the most noticeable change in expression (Fig. 1) and activity (Fig. 2). We thus assayed caspase 3 activity in cultures exposed to a range of EGF concentrations in the presence or absence of AG 1478, a specific inhibitor of EGF receptor tyrosine kinase (22). We found that the highest level of EGF, (100 ng/mL) maximally reduced the caspase activity to 60% of control values (Fig. 4B). However, caspase 3 activity remained at control levels when AG 1478 was present, with or without EGF additions (Fig. 4B). These results indicate that EGF, a known inducer of trophoblast differentiation, lowers caspase activity in cultured trophoblasts, with the most pronounced effect on caspase 3. In addition, the effect of EGF on caspase 3 activity in trophoblast is likely mediated through the EGFR.

Figure 4
figure 4

(A) Caspase activity in primary trophoblasts cultured for 24 h in the absence (control) or presence of EGF (100 ng/mL). Data are mean (±SD) percent of the caspase activity in control cultures from six independent primary trophoblast cultures. Mean caspase activity in control cultures was 6751 cRFU for caspase 3, 3008 cRFU for caspase 6, 3776 cRFU for caspase 8, and 1721 cRFU for caspase 9. The activities of caspases 3, 6, and 9 in cultures with EGF were significantly lower than control (*p < 0.05). (B) Caspase 3 activity in trophoblasts cultured for 24 h in standard medium in the absence (control) or presence of increasing concentrations of EGF, with 1 μM AG1478 where indicated. Data are mean (±SD) percent of the caspase activity in control cultures. Results are from six independent primary trophoblast cultures. *p < 0.05 compared with control.

DISCUSSION

We studied the role of caspases in trophoblast to gain insight into the contribution of caspases to the differential susceptibility of the two trophoblast phenotypes to apoptotic stimuli. The western analyses demonstrated that both cytotrophoblasts and syncytiotrophoblasts express the four pro-forms of the caspases studied with higher levels of pro-caspase 3 present in cytotrophoblasts. Despite a lack of difference in protein expression of pro-caspases 6, 8, and 9, the assessment of enzyme activities showed marked differences between the two phenotypes for all caspases evaluated. The highest caspase activity was found in cytotrophoblasts, and caspase activity decreased with trophoblast differentiation. Three lines of evidence support this premise:1) There was a higher caspase activity in cytotrophoblasts present at 24 h under standard conditions, compared with cultures at 72 h that contained differentiated syncytiotrophoblasts. 2) Compared with cultures grown 72 h in standard conditions, the activity of all four caspases was substantially higher when cells were cultured 72 h in DMSO (19) or colchicine (20), which are known to hinder differentiation and maintain the cytotrophoblast phenotype. 3) Total caspase activity of cells whose differentiation was enhanced by exposure for 24 h to EGF was significantly lower than caspase activity in control cells grown 24 h without ligand. We speculate that modulation of caspase activity in trophoblast may be important in the differentiation process of these cells and may also contribute to the differential sensitivity to hypoxia (8) exhibited by the two villous trophoblast phenotypes.

Villous trophoblasts undergo morphologic and biochemical differentiation in vivo and in vitro, as mononucleated cytotrophoblasts fuse to form the multinucleated syncytiotrophoblasts, which secrete hCG (23). Apoptosis also occurs in the trophoblast layer of placental villi (1, 2), especially at sites of syncytial knots (24). The differentiation and apoptotic pathways in trophoblasts have several features in common, and others have suggested that they are co-regulated as cytotrophoblasts become syncytiotrophoblasts (13, 14). For example, phosphatidylserine is exteriorized on the surface membrane of cells during apoptosis (9), but this phospholipid is externalized as part of both the apoptotic and differentiation processes in trophoblasts (13, 25). Caspases influence differentiation of a variety of cells (10–12). The presence of different enzyme activities in cytotrophoblasts and syncytiotrophoblasts suggests that the regulation of caspase activity may be part of the differentiation program. Alternatively, the higher caspase activities in cytotrophoblasts may be necessary to cleave substrates important to the formation of syncytiotrophoblasts. Further studies are needed to determine what role caspases may play in trophoblast differentiation, independent of their role in apoptosis.

Hypoxia and thromboxane treatment hinder differentiation (7, 26, 27), and enhance apoptosis in cultured trophoblast (8, 27). Importantly, undifferentiated cytotrophoblasts are most susceptible to the apoptosis induced by apoptotic stimuli while the syncytiotrophoblast is relatively resistant (8, 27). Our caspase studies point to one mechanism that explains this differential susceptibility. Pro-caspases reside intracellularly in a latent form with enzyme activity of ≤2% of the caspase (16, 17). After cell exposure to an activating stimulus, caspases undergo aggregation and enhanced autocatalytic cleavage that amplifies latent enzyme activity to yield the fully active caspase. Our data suggest that the higher endogenous caspase activity in the cytotrophoblasts sets a lower threshold for these cells to undergo apoptosis when exposed to apoptotic stimuli like hypoxia. Accordingly, the lower endogenous caspase activity in syncytiotrophoblast would make this phenotype less susceptible to apoptosis induced by exogenous stimuli. Preeclampsia and fetal growth restriction are associated with villous hypoxia and enhanced trophoblast apoptosis (3–6, 28). If hypoxia induces apoptosis of trophoblast in vivo in a manner similar to cultured trophoblast, drugs that inhibit caspases may provide a therapeutic approach to modulate the deleterious effects of these enzymes. This approach has been recently tested in the brain, where caspase inhibitors reduced the level of apoptosis after exposure to either hypoxic-ischemic or infectious insults (29, 30). Further investigation into the role of caspases in trophoblast apoptosis should be revealing.